Since 2016, the FDA has received more than 25 reports of confusion between the nasal solution and injectable products, including one report in 2024 of a patient who was injected with the nasal ...
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...
"We do not see, from where I sit, a possibility of a military solution to the challenges that face the eastern DRC," he told reporters during a briefing. "It was, it is, and am sure it will ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Over the next four years, all indications are that Donald Trump and Benjamin Netanyahu may extinguish any possibility of a two-state solution in the Middle East. Many of Israel's far-right ...
Continue to breathe calmly through your mouth. The saltwater solution will fill your nasal passages and sinuses, cross behind the nasal septum and exit from your lower nostril into the sink.
Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
A nasal rinse is a common practice to clear nasal passages, especially during cold, flu, and allergy seasons. It helps remove mucus, debris, and allergens that build in the nose. “A saltwater rinse is ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...
It seems Call of Duty: Black Ops 6 isn’t getting rid of its problems anytime soon. Every day it’s a new issue for the most recent installment of this highly coveted franchise. Forget the controversies ...